Eitan et al., 2006 - Google Patents
Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalitiesEitan et al., 2006
View PDF- Document ID
- 2503742886643968115
- Author
- Eitan R
- Lerer B
- Publication year
- Publication venue
- Dialogues in clinical neuroscience
External Links
Snippet
Until recently, a review of nonpharmacological, somatic treatments of psychiatric disorders would have included only electroconvulsive therapy (ECT). This situation is now changing very substantially Although ECT remains the only modality in widespread clinical use …
- 238000002635 electroconvulsive therapy 0 title abstract description 187
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36082—Cognitive or psychiatric applications, e.g. dementia, Alzheimer's, depression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0622—Optical stimulation for exciting neural tissue
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Eitan et al. | Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities | |
| Papp et al. | Perspectives for therapy of treatment‐resistant depression | |
| Marangell et al. | Neurostimulation therapies in depression: a review of new modalities | |
| Liebetanz et al. | Anticonvulsant effects of transcranial direct‐current stimulation (tDCS) in the rat cortical ramp model of focal epilepsy | |
| Chung et al. | Theta‐burst stimulation: A new form of TMS treatment for depression? | |
| Moretti et al. | rTMS-induced changes in glutamatergic and dopaminergic systems: relevance to cocaine and methamphetamine use disorders | |
| Howland | Vagus nerve stimulation | |
| DosSantos et al. | Potential mechanisms supporting the value of motor cortex stimulation to treat chronic pain syndromes | |
| Nitsche et al. | Treatment of depression with transcranial direct current stimulation (tDCS): a review | |
| Janicak et al. | Principles and practice of psychopharmacotherapy | |
| Hosomi et al. | Modulating the pain network—neurostimulation for central poststroke pain | |
| Puigdemont et al. | Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression | |
| Cunningham et al. | Induction of c-Fos and ΔFosB immunoreactivity in rat brain by vagal nerve stimulation | |
| Daban et al. | Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review | |
| Hescham et al. | Deep brain stimulation in dementia-related disorders | |
| DosSantos et al. | The contribution of endogenous modulatory systems to TMS‐and tDCS‐induced analgesia: Evidence from PET studies | |
| Luber et al. | Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging | |
| Smirni et al. | Modulating phonemic fluency performance in healthy subjects with transcranial magnetic stimulation over the left or right lateral frontal cortex | |
| Cole et al. | Evidence supporting deep brain stimulation of the medial septum in the treatment of temporal lobe epilepsy | |
| Tahtis et al. | Parkinson's disease treatments: focus on transcranial direct current stimulation (tDCS) | |
| Lisanby | Brain stimulation in psychiatric treatment | |
| Kirton et al. | Pediatric brain stimulation: Mapping and modulating the developing brain | |
| Li et al. | Progress in treatment of pathological neuropathic pain after spinal cord injury | |
| Short et al. | Non-invasive brain stimulation approaches to fibromyalgia pain | |
| De Herdt et al. | Modulation of seizure threshold by vagus nerve stimulation in an animal model for motor seizures |